Qi et al. obtained a higher risk of metastasis in HER2-positive patients than in HER2-negative patients in their analysis of risk factors for developing internal breast lymph node metastasis in BC [44], which is consistent with the results of our study. Here, ERBB2 is linked to breast cancer.